Evidence-based Emergency Care for Opioid Use Disorder

Program Release: April 26, 2021 Expiration Date: April 26, 2023 Estimated time to complete: 60 Minutes There are no prerequisites for participation Overview This program describes the current evidence for treatment of opioid use disorder in the Emergency Department and outlines practices for clinical management of patients with opioid use disorder. Practical instruction for initiation of medications for use disorder is provided. The goal by the end of the lecture is that providers will feel comfortable offering and providing a spectrum of evidence-based care for patients with opioid use disorder in the ED including medications for opioid use disorder naloxone, harm reduction resources, and linkage to follow up substance use treatment services and peer recovery specialists. ACKNOWLEDGEMENT OF FUNDING Funding provided by a Centers for Disease Control and Prevention ROI CE1900I Grant

After participating in this activity, the learner should be better able to: 

1. Identify management strategies for patients with opioid use disorder  experiencing acute pain or undergoing surgery
2. Describe the current state of evidence around peri-operative management of patients taking buprenorphine
3. Access the various resources available to aid in management of patients with opioid use disorder experiencing acute pain or undergoing surgery

METHOD OF PARTICIPATION AND HOW TO RECEIVE CME CREDIT

• Review the activity objectives, faculty information, and CME information prior to participating in the activity.
• View the presentation
• Complete the quiz with a passing score of 75% or higher, as well as the activity evaluation. You will then have immediate access to claiming credit and obtaining your certificate. 

FACULTY DISCLOSURE

In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.

The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.

This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.

Faculty Disclosure/Conflict of Interest

The following speakers and planning committee members* have indicated that they have no relevant financial relationships to disclose:

Collette Onyejekwe, PharmD, RPh*
Elizabeth Samuels, MD, MPH, MHS
Maria Sullivan*
Rachel S. Wightman, MD
 

DISCLAIMER AND PRIVACY POLICY

Privacy Policy: The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request.

Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.